Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721494 · ClinicalTrials.gov registry record · Phase 2
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
A Phase 2 study of Methamphetamine Abuse and Methamphetamine Disorders, sponsored by Clear Scientific.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06721494 is a Phase 2 study of Methamphetamine Abuse and Methamphetamine Disorders that is actively recruiting participants, run by Clear Scientific. The registered enrollment target is 40 participants, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06721494, a Phase 2 study of Methamphetamine Abuse and Methamphetamine Disorders, is actively recruiting participants, sponsored by Clear Scientific.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).
Conditions Studied
Interventions
- DRUG Methamphetamine
- DRUG Sterile Saline
- DRUG CS-1103
Study Locations (1)
California
- California Clinical Trials Medical Group - Glendale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-05 |
| Est. Completion | 2026-09-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06721494
The ClinicalTrials.gov registry entry for NCT06721494 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower). The listed sponsor is Clear Scientific, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Methamphetamine Abuse appearing as the primary indexed condition, and to 3 interventions - of which Methamphetamine is the first listed.
NCT06721494 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06721494 about?
NCT06721494 is a clinical study titled "A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine". The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose ...
What is the current status of trial NCT06721494?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2026-02-05. Estimated completion is 2026-09-11.
What conditions does trial NCT06721494 study?
This clinical trial studies the following conditions: Methamphetamine Abuse, Methamphetamine Disorders, Methamphetamine Intoxication.
What interventions are being tested in trial NCT06721494?
The interventions under investigation include: Methamphetamine (DRUG), Sterile Saline (DRUG), CS-1103 (DRUG).
Who is sponsoring clinical trial NCT06721494?
This trial is sponsored by Clear Scientific, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06721494 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine for Methamphetamine Use Disorder
RECRUITING · Phase 2
-
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
COMPLETED · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.